Skip to content
Open access

Treatment of Mixed Dry Eye Disease with Topical Azithromycin: A Prospective Controlled Pilot Study

Sep 2026 · Journal of Clinical Medicine · Vol 15, pp. 7549 · 0 citations · 51 references
Medicine

TL;DR

In this pilot cohort, second-line treatment of mixed DED with topical azithromycin significantly improved disease symptoms and signs, supporting its potential as a treatment option.

Abstract

Background: This study evaluated the efficacy of topical azithromycin ophthalmic solution (Azyter®, 15 mg/g) as second-line treatment for mixed dry eye disease (DED), given the drug’s known non-antimicrobial anti-inflammatory and immunomodulatory properties. Methods: In this pilot, prospective, controlled, non-randomized interventional study, fifteen patients with mixed DED refractory to first-line treatment received topical azithromycin for 30 days (twice daily for 3 days, then once daily for 27 days); ten healthy individuals served as controls. Clinical evaluation was performed before and after treatment in the study group and once in controls, and included the Dry Eye Questionnaire-5 (DEQ-5), Schirmer test, non-invasive tear break-up time (NITBUT, Sirius PLUS corneal topography), tear meniscus height (TMH; Sirius PLUS corneal topography), Efron scale grading of blepharitis, meibomian gland dysfunction (MGD), and conjunctival hyperemia; Oxford-scale grading of corneal fluorescein staining, and corneal epithelial thickness (swept-source anterior segment optical coherence tomography, AS-SS-OCT). Results: After treatment, DEQ-5 scores improved significantly (p < 0.001) and no longer differed from controls. Schirmer test and NITBUT values increased significantly (p = 0.003 and p = 0.027, respectively), becoming comparable to controls. Blepharitis, MGD, and corneal fluorescein staining scores also improved significantly (p < 0.001, p < 0.001, p = 0.002), as did maximum corneal epithelial thickness (p = 0.037). Conclusions: In this pilot cohort, second-line treatment of mixed DED with topical azithromycin significantly improved disease symptoms and signs, supporting its potential as a treatment option. Larger randomized studies are needed to confirm these findings and determine the optimal treatment regimen and duration.

Read PDF

Similar papers

Sep 2026

Evaluating the efficacy of topical tea tree oil versus preservative-free azithromycin in the treatment of dry eye disease associated with meibomian gland dysfunction: A randomized controlled trial focusing on tear interleukin levels.

PURPOSE Meibomian gland dysfunction (MGD) is a leading cause of dry eye disease (DED) and is associated with ocular surface inflammation characterized by elevated tear cytokines. METHODS In this single-masked, randomized, parallel-group clinical trial, 50 adults with meibomian gland dysfunction (MGD)-associated dry e...

Dalia R. El-Afify, Rewan H. H. Mahmoud, F. A. Kotkata et al. · 0 citations
Clinical trial Open access Sep 2026

Comparative study on the clinical effectiveness of low-concentration cyclosporine eye drops in patients with dry eye disease

Purpose This study aimed to evaluate the efficacy and safety of low-concentration, nanoparticle-based cyclosporine eye drops (SCAI-001 0.01% and SCAI-001 0.02%) compared to those of the conventional Restasis® (cyclosporine 0.05%) emulsion for dry eye disease (DED). Methods In this multicenter, randomized, double-blind,...

Jae Hyun Kim, H. Kim, Y. Shin et al. · 0 citations
Oct 2026

Topical Insulin in the Treatment of Ocular Surface Disease: A Retrospective Cohort Study.

PURPOSE To assess the efficacy of topical insulin for the treatment of various ocular surface diseases. METHODS A retrospective, multicenter cohort study was conducted at the university hospitals of Brussels and Ghent and included 57 eyes (45 patients) treated with topical insulin (1 IU/mL 4 times daily) for neurotro...

Marie Lammens, D. Roels, Silke Oellerich et al. · 0 citations
Open access Sep 2026

Evaluating the Efficacy of Topical Insulin Compared with Preservative-Free Artificial Tears in Ocular Surface Restoration among Patients with Dry Eye Disease: A Randomized Controlled Trial

Purpose:  To evaluate the efficacy of topical insulin (1 U/mL) compared with preservative-free artificial tears in improving ocular surface parameters in patients with Dry Eye Disease (DED). Study Design:  Randomized Controlled Trial. Place and Duration of Study:  Department of Ophthalmology,Khyber Teaching Hospital, f...

Shafiq Tanveer, Rasheed Ul Haq, Andaleeb Rabbi et al. · 0 citations
Review Open access Oct 2026

Documented Dry Eye Disease in Patients Receiving Topical Antiglaucoma Therapy: Associations with Treatment Characteristics

Background/Objectives: Chronic topical antiglaucoma therapy may affect the ocular surface. We assessed documented dry eye disease (DED) and its associations with active-ingredient burden, treatment duration, and preservative exposure. Methods: This retrospective cross-sectional study included 357 adults receiving topic...

Marija Jelić Vuković, Ena Kolak, D. Biuk et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.